Literature DB >> 12630438

Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign.

Kari Koskinen1, Eero Pukkala, Kari Reijula, Antti Karjalainen.   

Abstract

OBJECTIVES: Cancer risk has been estimated for asbestos production workers or other heavily exposed asbestos workers in numerous studies. The bulk of the asbestos epidemic results come, however, from past intermittent exposures during asbestos product use. This study concentrated on estimating the risk of cancer in such a population.
METHODS: Altogether 23285 men and 930 women invited to a nationwide screening campaign for benign asbestos-related diseases in 1990-1992 were followed for cancer through the Finnish Cancer Register up to 1998. Standardized incidence ratios (SIR) were calculated in comparison with the total Finnish population.
RESULTS: Altogether 1392 cases of cancer were found among the men. The risk was slightly, but significantly elevated for lung cancer [SIR 1.14, 95% confidence interval (95% CI) 1.01-1.26), mesothelioma (SIR 2.77, 95% CI 1.66-4.31), and prostate cancer (SIR 1.21, 95% CI 1.09-1.34). The risk of lung cancer was slightly higher among the invited nonparticipants (SIR 1.48, 95% CI 1.20-1.79) than among the participants (SIR 1.02, 95% CI 0.88-1.17). About 98% of the lung cancers occurred in current or ex-smokers.
CONCLUSIONS: In a population of long-term construction workers, the risk of lung cancer and mesothelioma was increased, but considerably lower than among insulators, asbestos sprayers, or patients with asbestosis. As it was not possible to follow most of the invited nonparticipants in the original screening study, selection bias by smoking or other life-style factors possibly correlated to the individual's decision to participate in the health screening cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630438     DOI: 10.5271/sjweh.706

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  7 in total

1.  Prostate cancer characteristics in the World Trade Center cohort, 2002-2013.

Authors:  Dana Hashim; Paolo Boffetta; Matthew Galsky; William Oh; Roberto Lucchini; Michael Crane; Benjamin Luft; Jaqueline Moline; Iris Udasin; Denise Harrison; Emanuela Taioli
Journal:  Eur J Cancer Prev       Date:  2018-07       Impact factor: 2.497

2.  Enduring health effects of asbestos use in Belgian industries: a record-linked cohort study of cause-specific mortality (2001-2009).

Authors:  Laura Van den Borre; Patrick Deboosere
Journal:  BMJ Open       Date:  2015-06-24       Impact factor: 2.692

3.  Stomach cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies.

Authors:  L Fortunato; L Rushton
Journal:  Br J Cancer       Date:  2015-04-30       Impact factor: 7.640

4.  Cancer Incidence in Asbestos-Exposed Workers: An Update on Four Finnish Cohorts.

Authors:  Pia Nynäs; Eero Pukkala; Harri Vainio; Panu Oksa
Journal:  Saf Health Work       Date:  2016-11-20

5.  Does exposure to asbestos cause prostate cancer? A systematic literature review and meta-analysis.

Authors:  Rui Peng; Fang Fang; Zhijun Chen; Shuai Yang; Changyuan Dai; Chengyong Wang; Han Guan; Qingwen Li
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

6.  Occupational Asbestos Exposure and Incidence of Colon and Rectal Cancers in French Men: The Asbestos-Related Diseases Cohort (ARDCo-Nut).

Authors:  Christophe Paris; Isabelle Thaon; Fabrice Hérin; Benedicte Clin; Aude Lacourt; Amandine Luc; Gaelle Coureau; Patrick Brochard; Soizick Chamming's; Antoine Gislard; Pilar Galan; Serge Hercberg; Pascal Wild; Jean-Claude Pairon; Pascal Andujar
Journal:  Environ Health Perspect       Date:  2016-08-12       Impact factor: 9.031

7.  Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis.

Authors:  Frédéric Dutheil; Laetitia Zaragoza-Civale; Bruno Pereira; Martial Mermillod; Julien S Baker; Jeannot Schmidt; Fares Moustafa; Valentin Navel
Journal:  Perm J       Date:  2020-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.